17 April 2023 - New treatment option for Canadians living with rare and serious X-chromosome linked congenital bleeding disorder ...
27 October 2022 - Expanded indication for Rebinyn will continue to support Canadian paediatric patients living with haemophilia B. ...
6 July 2022 - New immunoglobulin treatment offers Canadian patients option of subcutaneous once-monthly (every three or four weeks) dosing. ...
14 February 2021 - Repeal of NDP bill last fall clears way for Canadian Plasma Resources to set up shop. ...
27 July 2019 - Agency clarifies its position on controversial treatment made popular by superstar athletes. ...
12 July 2019 - New treatment can help Canadians living with haemophilia A better manage their bleeding episodes ...
26 November 2018 - Canadian children now have access to Adynovate, which offers a twice-weekly prophylaxis dosing schedule and on-demand control ...
24 October 2018 - Extended half-life product that offers a reduction in dosing frequency and improved bleeding protection. ...
9 August 2017 - CSL Behring is pleased to announce that on 31 March 2017 Berinert (C1 esterase inhibitor, human) was ...
14 December 2016 - Afstyla is the first and only single-chain recombinant factor VIII for haemophilia A, specifically designed for ...